- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/08 - Bridged systems
Patent holdings for IPC class C07D 513/08
Total number of patents in this class: 165
10-year publication summary
|
15
|
6
|
10
|
12
|
10
|
19
|
5
|
16
|
10
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4074 |
26 |
| Gilead Sciences, Inc. | 2036 |
15 |
| Janssen Pharmaceuticals, Inc. | 433 |
7 |
| Katholieke Universiteit Leuven | 1191 |
7 |
| The Texas a & M University System | 1698 |
6 |
| Nektar Therapeutics | 435 |
5 |
| Shionogi & Co., Ltd. | 854 |
5 |
| Kasis Environmental Ltd. | 5 |
5 |
| Vasthera Co. Ltd. | 13 |
5 |
| City of Hope | 989 |
4 |
| Achillion Pharmaceuticals, Inc. | 164 |
3 |
| Medizinische Hochschule Hannover | 282 |
3 |
| The Board of Regents of the University of Texas System | 2206 |
3 |
| Onkure, Inc. | 26 |
3 |
| Merck Sharp & Dohme LLC | 3748 |
3 |
| Novartis AG | 10849 |
2 |
| The Regents of the University of California | 19918 |
2 |
| Janssen Pharmaceutica N.V. | 3392 |
2 |
| Bayer Schering Pharma AG | 385 |
2 |
| Ajinomoto Co., Inc. | 2295 |
2 |
| Other owners | 55 |